FCGR3A and asthma: One study of patients with asthma in Poland showed a significant increase in the frequency of CD14++CD16+ monocytes in patients with severe asthma compared to healthy controls or patients with mild and moderate asthma [22] and it was suggested that this increase in the intermediate population might be a useful biomarker for asthma severity.